Live Breaking News & Updates on Interpretations International Financial Reporting Interpretation Committee

Stay updated with breaking news from Interpretations international financial reporting interpretation committee. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Investegate |Angle PLC Announcements | Angle PLC: Results for the year ended 31 December 2022

Investegate announcements from Angle PLC, Results for the year ended 31 December 2022 ....

New Zealand , Plymouth Meeting , United States , United Kingdom , Czech Republic , Simon Conway , Ciaran Walsh , Andrew Newland , Juliet Thompson , Ian Griffiths , Parsortix Ctcs , Shaam Vora , Ciara Martin , Toby Flaux , Garth Selvey , Joe Eid , Thomas Bective , Milo Bonser , Employee Share Ownership Trust , Company United States , Registrar Of Companies , Swiss Federal Institute Of Technology , Medicaid Services , Centers For Medicare , Surrey Research Park , Solaris Health ,

Angle PLC Announces Results for the Year Ended 31 December 2022

Preliminary Results for the year ended 31 December 2022FDA CLEARANCE A MAJOR BREAKTHROUGH FOR PARSORTIX LIQUID BIOPSParsortix system substantially out-performs standard of care for ovarian cancer diagnosisProstate ....

New Zealand , Czech Republic , United States , United Kingdom , City Of , Plymouth Meeting , Andrew Newland , Milo Bonser , Shaam Vora , Toby Flaux , Garth Selvey , Ciaran Walsh , Ian Griffiths , Ciara Martin , Juliet Thompson , Simon Conway , Parsortix Ctcs , Thomas Bective , Joe Eid , Investor Centre , Company United States , Financial Conduct Authority , Molecular Oncology Laboratory , London Stock Exchange , Centers For Medicare , Interpretations International Financial Reporting Interpretation Committee ,

Investegate |Angle PLC Announcements | Angle PLC: Preliminary Results

ANGLE plc (AIM: AGL OTCQX: ANPCY), a world-leading liquid biopsy company, today announces audited preliminary results for the year ended 31 December 2020.

· Full De Novo Submission made in September 2020 for US Food and Drug Administration (FDA) clearance of the Parsortix
® system for capturing and harvesting circulating tumour cells from metastatic breast cancer patients
- FDA Administrative Review complete and Substantive Review in progress
- FDA Additional Information Request (AIR) received and response planned for submission in May 2021

- patient enrolment completed after the year end
- surgical procedures in progress and sample analysis in preparation
- study expected to report headline results in Q4 2021 ....

New York , United States , Nordrhein Westfalen , United Kingdom , Plymouth Meeting , University Of Rochester Medical Center , Western Australia , Carl Holmes , Ciara Martin , Istituto Nazionale Tumori , Simon Hicks , Teddy Whiley , Andrew Newland , Andrew Craig , Nigel Barnes , Nigel Birks , Garth Selvey , Osimertinib Astrazeneca Tagrisso , Ian Griffiths , Simon Conway , Laboratory Of Translational Oncology , School Of Medicine , University Of Southern California , University Of Basel , University Medical Center Hamburg , Registrar Of Companies ,